Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ECARX Holdings (ECX) Research & Development: 2021-2025

Historic Research & Development for ECARX Holdings (ECX) over the last 5 years, with Sep 2025 value amounting to -$25.9 million.

  • ECARX Holdings' Research & Development rose 45.82% to -$25.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$344.7 million, marking a year-over-year increase of 14.00%. This contributed to the annual value of $172.6 million for FY2024, which is 3.53% down from last year.
  • As of Q3 2025, ECARX Holdings' Research & Development stood at -$25.9 million, which was up 23.37% from -$33.8 million recorded in Q2 2025.
  • Over the past 5 years, ECARX Holdings' Research & Development peaked at -$25.9 million during Q3 2025, and registered a low of -$508.4 million during Q4 2022.
  • Its 3-year average for Research & Development is -$206.9 million, with a median of -$243.7 million in 2023.
  • In the last 5 years, ECARX Holdings' Research & Development tumbled by 71.45% in 2023 and then soared by 84.55% in 2024.
  • ECARX Holdings' Research & Development (MRQ) stood at -$372.3 million in 2021, then tumbled by 36.56% to -$508.4 million in 2022, then rose by 6.88% to -$473.4 million in 2023, then grew by 27.74% to -$342.1 million in 2024, then surged by 92.43% to -$25.9 million in 2025.
  • Its last three reported values are -$25.9 million in Q3 2025, -$33.8 million for Q2 2025, and -$251.2 million during Q1 2025.